Indian stocks: Visit www.stage2stocks.com →

Precipio, Inc.

Stage 2 · Advancing · week 7

As of Oct 22, 2026, Precipio is in Stage 2, the uptrend phase, now in week 7 (since Sep 9, 2026). It closed at $20.61, 36.3% below its 52-week high and below its 200-day average, which is falling.

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. More about the company

$20.61
-3.01% today
$36.9M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 32 in Diagnostics & Research · #1 of 272 in Health Care

Is PRPO early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 13w
S4 17w
S2 39w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 12w → S1 9w → S4 13w → S1 3w → S4 17w → S1 5w → S2 7w → S3 6w → S4 4w → S3 1w → S2 10w → S3 4w → S4 1w → S3 2w → S2 39w → S3 2w → S2 12w → S3 7w → S4 4w → S1 2w → S2 6w current
Total tracked: 165 weeks across 21 stage runs.

PRPO among Diagnostics & Research29th of 44 by relative strength

All 44 →
Stocks in Diagnostics & Research ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CDNAStage 2 · wk 2499+27.3%
2BDSXStage 2 · wk 1898−18.3%
3ILMNStage 2 · wk 2497+5.5%
4GHStage 2 · wk 2197−7.6%
5NTRAStage 2 · wk 2096+2.7%
6CRLStage 2 · wk 1692+22.5%
7RVTYStage 2 · wk 1890+10.7%
8PSNLStage 2 · wk 1790−3.2%
…29PRPOStage 2 · wk 750−13.5%
vs 52W High
-36.3%
$19.33 lo$32.37 hi
36.3% below 52W high, far from high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 7
1w13w26w
Week 7, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
-18.1%
200 DMA: $25.15 · sloping down
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.23x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-13.5%
3M
-13.0%
6M
-23.8%
YTD
-13.5%
1Y
-4.9%
Scan Membership
Breakout Watch
Latest: 2025-05-29
7 appearances in last 60 days. First seen: 2019-05-14.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 7 · Vol 0.23x
2026-10-21S2
Wk 7 · Vol 0.97x
2026-10-20S2
Wk 6 · Vol 0.21x
2026-10-19S2
Wk 6 · Vol 0.19x
2026-10-16S2
Wk 6 · Vol 0.77x
2026-10-15S2
Wk 6 · Vol 0.37x
2026-10-14S2
Wk 6 · Vol 0.35x
2026-10-13S2
Wk 5 · Vol 0.24x
2026-10-12S2
Wk 5 · Vol 0.10x
2026-10-09S2
Wk 5 · Vol 0.17x
2026-10-08S2
Wk 5 · Vol 0.93x
2026-10-07S2
Wk 5 · Vol 0.52x
Moving averages & range
50 DMA
$25.35
200 DMA
$25.15
52W High
$32.37
52W Low
$19.33
5D Low
$20.61
Resistance levels (recent highs)
20d High
$24.11
60d High
$31.12
120d High
$32.37
250d High
$32.37
Next resistance
+17.0%
to 20d High
ROE
-9.0%
Profit margin -4.5%
Dividend Yield
0.00%
P/B 2.5

Precipio: quick answers

What stage is Precipio in?

As of Oct 22, 2026, Precipio (PRPO) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 9, 2026 and is in week 7. What the four stages mean

Is Precipio in an uptrend?

Yes. Precipio is in a Stage 2 uptrend. It trades 18.1% below its 200-day average, which is falling.

How far is Precipio from its 52-week high?

Precipio closed at $20.61 on Oct 22, 2026, 36.3% below its 52-week high of $32.37. Its 52-week low is $19.33.

How has Precipio performed over the past year?

As of Oct 22, 2026, Precipio is down 4.9% over the past year and down 13.5% so far in 2026.

Which sector and industry is Precipio in?

Precipio is in the Diagnostics & Research industry, part of the Health Care sector.

About this companyHealth Care· Diagnostics & Research

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.